Author(s):
Daniel Whalen
Introduction:
The market for interventional cardiology (IC) devices in Europe has matured as both the growth and penetration of the eligible coronary artery disease (CAD) patient population has stabilized. Nevertheless, as the incidence of CAD rises across Europe, this group will further expand over the forecast period, along with procedure volumes and device sales. Penetration and sales will also rise as a result of clinical data and product innovations continuing to promote treatment of more complicated forms of the disease using percutaneous coronary intervention (PCI). Price erosion will have a significant effect on market growth, however, with revenues declining slightly through 2013.
Questions Answered in This Report:
* The use of drug-eluting stents (DES) has resurged, with concerns over safety, first raised in 2006, having largely subsided.
How have the DES markets of the countries covered varied in their recovery? Which clinical studies and new products have strengthened physicians' confidence? * Innovations in IC device technology have enabled physicians to treat more complicated coronary artery blockages.
Which device types have seen innovation? Which patient indications are being targeted? How have these techniques fared in clinical studies? * European physicians vary widely in their preference for either percutaneous transluminal coronary angioplasty (PTA) with stent or direct stenting methods of implanting coronary stents.
In which countries is each method the most popular? How will evolving device capabilities affect physicians' preferences? * Adoption of intravascular ultrasound (IVUS) technology has allowed for superior stent placement and is becoming increasingly popular.
How many PCIs currently use IVUS, and how will these figures change through 2013? How will the adoption of IVUS affect other imaging techniques? * Diagnosis-related group reimbursement systems in France, Germany, and Italy provide general reimbursement for IC procedures; the UK’s National Institute for Health and Clinical Excellence limits the premium that can be charged for DES.
How is legislation affecting the use and pricing of IC devices? How does this affect the competitive landscapes among the countries covered?Scope:
Regions covered: France, Germany, Italy, and the UK
Segmentation: Our analysis uses the following segmentation of the market:
- Coronary stents
- PTCA balloon catheters
- IC accessory devices
- PTCA guidewires (workhorse and specialty)
- Diagnostic catheters
- PTCA guiding catheters
- Introducer sheaths
- IVUS catheters
Market forecast features: Based on primary research with industry professionals, we use our proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, average selling prices, and market values over a 7-year period (2007–2013).
Competitive analysis: We provide a detailed analysis of the competitive landscape in the market, as well as market shares and qualitative discussions of the leading competitors in each market segment.